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Abstract: β-Lactams represent flexible building blocks suitable for the preparation of a large
variety of nitrogen-containing target compounds. In the present study, the formerly neglected
synthetic potential of 4-haloalkyl-β-lactams has been elaborated in detail with a focus on the
preparation of different mono- and bicyclic heterocycles. A first approach involved ring
transformations of these halogenated building blocks toward stereodefined aziridines, aze-
tidines, pyrrolidines, and piperidines via intermediate aziridinium or azetidinium ions. In a
second part, novel and stereoselective entries into 1,4- and 3,4-fused bicyclic β-lactams were
developed through either a radical or an ionic cyclization protocol. Furthermore, the ring
enlarge ment of halogenated β-lactams into functionalized mono- and bicyclic pyrrolidin-2-
ones was established as the aza-analog of the cyclobutylmethylcarbenium ion to cyclo -
pentylcarbenium ion rearrangement. Finally, chiral versions toward azetidin-2-ones and ring
transformation products were elaborated, involving the synthesis of 3(S)-alkoxy-4(S)-
[1(S)-chloroethyl]azetidin-2-ones and the preparation of bicyclic β-lactams annelated to
piperazines, morpholines, and diazepanes.
Keywords: azetidines; aziridines; β-lactams; γ-lactams; piperidines; pyrrolidines; stereo -
selectivity.
INTRODUCTION
The class of β-lactam antibiotics is generally recognized as a cornerstone of human health care due to
the unparalleled clinical efficacy and safety of this type of antibacterials [1]. For example, the world
anti biotics market is dominated by Augmentin, a combination of amoxicillin 1 and potassium clavu-
lanate 2, produced by GlaxoSmithKline. Nevertheless, the recent appearance of highly resistant bacte-
ria profoundly challenges the way medicinal chemists contemplate innovation of the β-lactam structure
and corroborates the need for continuous efforts within this field of research.
Besides their biological relevance as potential antibiotics, β-lactams have also acquired a promi-
nent place in organic chemistry as synthons for further elaboration [2,3]. In this way, the azetidin-2-one
framework has already demonstrated its utility for the construction of a wide variety of novel
(aza)hetero cyles, which can serve as lead compounds for the development of new biologically relevant
targets.
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Within drug discovery and medicinal chemistry, the introduction of structural diversity and nov-
elty is of primordial importance in order to cope with the emerging bacterial resistance. In that context,
a suitable synthetic strategy toward novel organic compounds comprises a non-target direct approach
starting from well-designed, easily accessible, and versatile building blocks. Indeed, the elaboration of
such substrates incontestably results in a rich chemistry, giving access to multiple classes of new com-
pounds with great diversity of functionalities.
In the present paper, the applicability of the mainly unexplored class of 4-(haloalkyl)azetidin-2-
ones is surveyed based on different synthetic protocols leading to the preparation of a large variety of
novel heterocyclic compounds and β-amino acid derivatives.
SYNTHESIS OF 4-(HALOALKYL)AZETIDIN-2-ONES
In continuation of our efforts regarding the synthesis and transformation of novel β-lactam scaffolds,
the evaluation of a new class of functionalized azetidin-2-ones bearing halogenated side chains was
contemplated. The interest in these types of substrates is due to the potential elaboration of their high
intrinsic reactivity, which is based on the combination of a strained four-membered ring system, a
nucleo philic nitrogen (or obtained after further elaboration), and an electrophilic center in the side
chain.
In particular, the synthesis of 4-haloalkyl-β-lactams was devised, in which the halogen atom re-
sides in β- or γ-position with respect to the nitrogen atom [4]. Thus, cyclocondensation of Bose–Evans
ketenes generated from phenoxy-, methoxy- or benzyloxyacetyl chloride in the presence of a base, and
α-chloroimines 3, prepared through α-chlorination of the corresponding imines using N-chlorosuccin-
imide in CCl4 [5] or via imination of α-chloroketones or α-chloroaldehydes with primary amines in the
presence of titanium(IV) chloride as water scavenger [6], afforded the corresponding cis-4-(1-
chloroalkyl)azetidin-2-ones 4 in high yields (Scheme 1). Accordingly, β-haloimines 5 were synthesized
via condensation of 3-halo-2,2-dimethylpropanal with the corresponding amine [7], and treated with ap-
propriate ketenes to furnish cis-4-(2-halo-1,1-dimethylethyl)-β-lactams 6 (Scheme 1). It should be
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Scheme 1 Synthesis of β-lactams 4 and 6.
noted that the Staudinger synthesis of β-lactams 4 and 6 proceeded in a highly diastereoselective way,
which can be attributed to the electron-donating alkoxy- or phenoxy group present in Bose–Evans
ketenes, favoring direct conrotatory ring closure of the Zwitterionic intermediates toward the corre-
sponding kinetic products [8].
In recent years, the introduction of chirality has become a key issue and challenge in medicinal
chemistry. Consequently, the development of chiral approaches (often catalytic methodologies) toward
β-lactams has gained much interest and has become the topic of intensive research. The Staudinger re-
action, using either a chiral ketene or a chiral imine, is generally acknowledged as the method of choice
for the asymmetric synthesis of β-lactams [9]. In light of the successful use of chiral α-oxy and α-amino
substituted aldehydes for the stereoselective synthesis of β-lactams, the application of chiral
α-chloroimines was evaluated as a potential tool useful for the synthesis of chiral 4-(1-chloroalkyl)-β-
lactams in a convenient way. The attainability of the concept was first evaluated using racemic sub-
strates, resulting in a racemic mixture of (S,S,S)- and (R,R,R)-4-(1-chloroethyl)-4-methyl-β-lactams 4
(R2 = Me, R3 = Me, R4 = H) in excellent diastereomeric excess starting from the appropriate
α-chloroketimines 3 (Scheme 1). The relative configuration of these 4-methylazetidin-2-ones 4 was
confirmed by X-ray analysis of one derivative. Based on these encouraging results, an asymmetric ver-
sion using chiral α-haloimines was developed. To obtain 4-(1-chloroethyl)azetidin-2-ones 8,
2(S)-chloro-1-propanol 7 was chosen as substrate for oxidation with pyridinium chlorochromate (PCC)
to 2(S)-chloropropanal, further imination with primary amines and Staudinger reaction. In this way, chi-
ral 4-(1-chloroethyl)azetidin-2-ones 8 were prepared for the first time in a one-pot synthesis in high dia -
stereomeric excess (80–89 %) and overall yields of 19–43 % (except for the 3-methoxy derivative in
6 %) (Scheme 2) [10]. The enantiomeric excess was shown to be 90 % through coupling of β-lactam 8
(R1 = Bu, R2 = Bn) with (R)-α-methoxy-α-trifluoromethyl phenylacetic acid and subsequent GC analy-
sis.
SYNTHETIC APPLICATIONS OF 4-(HALOALKYL)AZETIDIN-2-ONES
4-Haloalkyl-β-lactams are ideally suited for the synthesis of stereodefined aziridines, azetidines, pyrro-
lidines, and piperidines due to the reactive combination of a constrained ring system, a halogenated car-
bon atom, and a nucleophilic nitrogen, either present or to be generated. 
Upon choice of the substrate and through variation of the reactions conditions, the inherent reac-
tivity can be tuned at will in order to prepare different azaheterocyclic compounds.
A first example involved the diastereoselective synthesis of functionalized aziridines and
 azetidines via reduction of 4-(1- or 2-haloalkyl)azetidin-2-ones. Treatment of the latter compounds with
LiAlH4 gave 1,2-fission of the β-lactam nucleus resulting in a lithium amide, followed by intra -
molecular substitution of the halogen atom giving rise to the formation of 2-(1-alkoxy-2-hydroxy -
ethyl)aziridines or -azetidines, respectively [11]. Thus, treatment of 4-(1-chloro-1-methylethyl)aze-
tidin-2-ones 9 with LiAlH4 in diethyl ether at 0 °C for 2 h afforded 2-(1-alkoxy-2-hydroxy -
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Scheme 2 Synthesis of β-lactams 8.
ethyl)aziridines 10 in 43–62 % yield, next to a small fraction of azetidines 11 in 2–5 % yield
(Scheme 3). This transformation proceeded with retention of stereochemistry, as defined during the
Staudinger synthesis of β-lactams 9. The synthetic relevance of 2-(1-alkoxy-2-hydroxy ethyl)aziridines
10 was demonstrated by means of their transformation into the corresponding trans-3,4-disubstituted
oxolanes 12 via an intramolecular nucleophilic ring opening, triggered by the addition of AlCl3 in di-
ethyl ether under reflux for 48 h (Scheme 3).
In analogy, treatment of 4-(2-bromo-1,1-dimethylethyl)azetidin-2-ones 13 with LiAlH4 in diethyl
ether at 0 °C for 2 h resulted in 2-(1-alkoxy-2-hydroxyethyl)azetidines 14 in 45–61 % yield, next to
small amounts of cis-4-(2-bromoalkyl)azetidines 15 (1–5 %) (Scheme 4) [11]. Again, the relative
stereo chemistry of azetidin-2-ones 13 was transferred through the reaction sequence, affording aze-
tidines 14 in a stereoselective way.
In a second approach, the nucleophilicity of the ring nitrogen atom was exploited prior to ring
opening of the four-membered scaffold. This methodology is based on the reduction of the β-lactam
carbonyl moiety without cleavage of the amide bond in order to enhance the nucleophilicity of the ring
nitrogen, followed by displacement of the halide by the nucleophilic nitrogen lone pair toward a reac-
tive bicyclic azetidinium intermediate.
Treatment of 4-(1-chloro-1-methylethyl)azetidin-2-ones 16 with monochloroalane (AlH2Cl), pre-
pared in situ from LiAlH4 and AlCl3, in diethyl ether at 0 °C furnished the corresponding 2-(1-chloro-
1-methylethyl)azetidines 17 in good yields (Scheme 5). Furthermore, the latter azetidines 17 proved to
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Scheme 3 Synthesis of aziridines 10 and oxolanes 12.
Scheme 4 Synthesis of azetidines 14.
be very useful starting materials for rearrangements toward stereospecifically defined 3,4-cis-disubsti-
tuted pyrrolidines. Indeed, when 2-(1-chloro-1-methylethyl)azetidines 17 were heated in acetonitrile
under reflux, 3-chloropyrrolidines 18 were obtained in 44–46 % yield (method a, Nu = Cl, Scheme 5)
[12]. Alternatively, several other nucleophiles were used successfully, affording 3-hydroxy-, 3-cyano-,
or 3-azidopyrrolidines 18 in 44–52 % yield upon treatment of azetidines 17 with NaOH, KCN, or NaN3
in DMSO at 100 °C for 18 h (method b, Nu = OH, CN, N3, Scheme 5). The cis-stereochemistry of the
pyrrolidines 18 was confirmed through nuclear Overhauser effect (nOe) experiments and analysis of
vicinal coupling constants, and was consistent with a reaction mechanism involving the formation and
consecutive ring opening of bicyclic azetidinium salts 19 (Scheme 5).
The same methodology, i.e., carbonyl to methylene reduction followed by ring transformation,
was applied on 4-(2-bromo-1,1-dimethylethyl)azetidin-2-ones 20. Treatment of the latter β-lactams 20
with monochloroalane in diethyl ether afforded 2-(2-bromo-1,1-dimethylethyl)azetidines 21, which
were subsequently transformed into cis-3-alkoxy-4-bromopiperidines 22 in excellent yields through re-
flux in acetonitrile for 3 h (Scheme 6) [12]. The observed cis-stereochemistry was rationalized consid-
ering the in situ formation of a bicyclic azetidinium intermediate 23, which is prone to ring opening by
the nucleophilic counter-ion, i.e., bromide, at the bridgehead carbon atom in a SN2 fashion. It should be
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Scheme 5 Synthesis of azetidines 17 and pyrrolidines 18.
Scheme 6 Synthesis of azetidines 21 and piperidines 22. 
noted that the occurrence of 1-azoniabicyclo[2.2.0]hexanes such as 23 was unprecedented in the chem-
ical literature.
Besides ring transformations of β-lactams based on the reductive removal of the carbonyl group,
other approaches have also been worked out. A synthetically versatile method in that respect comprises
the ring expansion of 4-(1-halo-1-methylethyl)azetidin-2-ones into functionalized γ-lactams via
N-acyliminium intermediates. For example, dissociation of the bromide in 4-(1-bromo-1-
methylethyl)azetidin-2-ones 24 gave rise to carbenium ions 28, which in their turn were converted into
stable N-acyliminium intermediates 29 via an intramolecular rearrangement upon stirring in dimethyl-
sulfoxide (DMSO). In principle, this ring expansion can be considered as the aza-analog of the cyclo -
butylmethylcarbenium ion rearrangement toward cyclopentanes or cyclopentenes. Subsequent attack of
different nucleophiles onto iminium salts 29 led to the formation of functionalized trans-γ-lactams 25
as the major reaction products, besides the corresponding cis-γ-lactams 26 and 4-isoprenylazetidin-2-
ones 27 (obtained via dehydrobromination) as minor constituents (Scheme 7) [13]. The degree of dia -
stereocontrol appeared to be dependent on both the type of nucleophile and the substituents present at
the starting azetidin-2-ones 24. When the same ring expansion was performed in tetrahydrofuran (THF)
as a solvent and in the presence of potassium tert-butoxide, trans-5-hydroxy-, and trans-5-
methoxypyrrolidin-2-ones 25 (Nu = OH, OMe) were obtained in a highly diastereoselective way
(64–71 %). Furthermore, no dehydrobromination was observed when using THF as a solvent instead of
DMSO. Attempts with sodium azide, allylamine, and potassium cyanide, however, failed.
Alternatively, the ring enlargement of β-lactams into γ-lactams was accomplished starting from
4-(1-methylethenyl)azetidin-2-ones 31 through the creation of an electrophilic center by the addition of
a suitable electrophile across the olefin [14]. The required 4-isoprenyl-β-lactams 31 were efficiently
synthesized starting from 4-(1-chloroalkyl)azetidin-2-ones 30 through dehydrochlorination in dry
DMSO at 160 °C for 4 h [14]. 4-(1-Alkenyl)-β-lactams can also be prepared via Staudinger reaction of
ketenes with α,β-unsaturated imines, which are accessible by 1,2-dehydrohalogenation of α-haloimines
or by condensation of enals with primary amines [15]. Subsequent treatment of β-lactams 31 with
1 equiv of bromine in dichloromethane resulted in a diastereoselective, electrophile-induced ring ex-
pansion toward 5-bromopyrrolidin-2-ones 32 via intermediate N-acyliminium salts. Remarkably, when
3-benzyloxy-4-isoprenylazetidin-2-ones 31 (R2 = Bn) were treated with 5 equiv of bromine for 4 h at
0 °C, oxidative cleavage of the benzyloxy moiety occurred, resulting in 3,5-dibromopyrrolidin-2-ones
33 in a diastereoselective fashion (Scheme 8). Besides bromine, the use of N-bromosuccinimide (NBS)
in the presence of azidotrimethylsilane (TMSN3) was shown to be successful, leading to the formation
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Scheme 7 Synthesis of pyrrolidin-2-ones 25.
of 5-azidopyrrolidin-2-ones 32 (Nu = N3) in moderate to high yields in a dichloro-/nitromethane (3/1)
solvent system at room temperature (Scheme 8).
Finally, the broad synthetic applicability of this β-lactam to γ-lactam ring expansion reaction
was demonstrated through the development of a full intramolecular version leading to functionalized
bicyclic γ-lactams [16]. In this context, 4-(1-chloro-1-methylethyl)-1-(ω-hydroxyalkyl)azetidin-2-
ones 34 were treated with AgBF4 and pyridine in toluene under reflux, resulting in the diastereose-
lective formation of novel trans-1-aza-4-oxabicyclo[3.3.0]octan-8-ones 35 and trans-1-aza-5-oxa -
bicyclo[4.3.0]nonan-9-ones 36, besides minor amounts of the corresponding cis-isomers 37 and 38
(Scheme 9). These observations could be explained considering the intramolecular nucleophilic trap-
ping of N-acyliminium intermediates, formed through AgBF4-mediated chloride dissociation, by the
hydroxyl moiety, in analogy with the above described reaction pathway (cf. Scheme 7). Furthermore,
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Scheme 9 Synthesis of bicyclic γ-lactams 35, 36, 40, and 41.
Scheme 8 Synthesis of pyrrolidin-2-ones 32 and 33.
the corresponding aza-analogs of bicyclic γ-lactams 35–38 were prepared accordingly, starting from
cis-4-(1-chloroalkyl)-1-{ω-[(tert-butoxycarbonyl)amino]alkyl}azetidin-2-ones 39. Thus, treatment
with AgBF4 and pyridine in toluene under reflux for 15 h furnished trans-1,4-diazabicyclo[3.3.0]octan-
8-ones 40 and trans-1,5-diazabicyclo[4.3.0]nonan-9-ones 41, next to minor amounts of the correspon-
ding cis-isomers 42 and 43 (Scheme 9). This approach involved the first general transformation of
monocyclic β-lactams into bicyclic γ-lactams via N-acyliminium intermediates.
A major incentive in β-lactam chemistry comprises the synthesis of novel bicyclic β-lactam sys-
tems as potential new analogs of the potent class of bicyclic β-lactam antibiotics. Within this frame-
work, different methodologies have been elaborated toward a variety of carbo- and heterocyclic 1,4- and
3,4-fused bicyclic azetidin-2-ones.
In a first approach, novel carbacepham derivatives 45 were prepared diastereoselectively through
radical cyclization of 4-(2-bromo-1,1-dimethylethyl)azetidin-2-ones 44 (Scheme 10) [17,18].
Treatment of 1-(2-propenyl)azetidin-2-ones 44 (R3 = H) with tributyltin hydride and azoisobutyronitrile
(AIBN) in toluene at reflux temperature for 18 h afforded 7-alkoxy-5,5-dimethyl-1-azabicylo[4.2.0]oc-
tane-8-ones 45 as single diastereomers through 6-exo-trig cyclization of intermediate methyl radicals,
besides a small amount (6–11 %) of the corresponding monocyclic 4-tert-butyl-β-lactams. The relative
stereochemistry of bicyclic β-lactams 45 was unequivocally established by means of X-ray analysis,
pointing to a cis-disposition between the bridgehead hydrogen atom and the methyl or benzyl sub-
stituent at the six-membered ring. 1-Azabicylo[4.2.0]octane-8-ones 45 are not only of interest from a
biological but also from a synthetical point of view, as was demonstrated by reductive ring opening by
means of LiAlH4 in diethyl ether at reflux temperature for 16 h. This approach enabled the preparation
of stereodefined 2-(1-alkoxy-2-hydroxyethyl)piperidines 46 as valuable members of the biologically
important class of functionalized piperidines (Scheme 10).
Interestingly, the use of β-lactams 44 bearing a 2-methyl-2-propenyl group at nitrogen allowed a
convenient entry into the higher homologues of azaheterocycles 45 through a 7-endo-trig cyclization
protocol via stable intermediate tertiary radicals. Thus, treatment of azetidin-2-ones 44 (R2 = H,
R3 = Me) with tributyltin hydride and azoisobutyronitrile in toluene afforded 3,6,6-trimethyl-1-azabi-
cyclo[5.2.0]nonan-9-ones 47 in a 87–89/11–13 diastereomeric ratio (trans-47/cis-47) (Scheme 10), be-
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Scheme 10 Synthesis of piperidines 46 and azepanes 48.
sides a small amount (7–11 %) of the corresponding 4-tert-butyl-β-lactams [17,18]. Steric hindrance is
probably the main factor orienting the cyclization to a 7-endo-trig selectivity in the case of bicyclic
β-lactams 47. Furthermore, the reduction of 1-azabicyclo[5.2.0]nonan-9-ones 47 with LiAlH4 in diethyl
ether at reflux temperature for 16 h afforded the corresponding diastereomeric mixture of 2-(1-alkoxy-
2-hydroxyethyl)azepanes, after which the major isomers trans-2-(1-alkoxy-2-hydroxyethyl)azepanes
48 were isolated in pure form upon column chromatography (Scheme 10).
In another approach, bicyclic β-lactams in which the second ring contains a heteroatom have been
prepared, although in this case optically active 4-formyl-1-(2- and 3-haloalkyl)azetidin-2-ones 49 [19]
were used as substrates. Treatment of the latter β-lactams 49 with NaBH4 in methanol under reflux for
1 h afforded the corresponding chiral 4-hydroxymethyl-β-lactams 50, which, upon reaction with NaH
in toluene and subsequent heating in DMSO, were transformed into bicyclic morpholine derivatives 51
(Scheme 11) [20]. To broaden the scope of this methodology, the synthesis of the corresponding nitro-
gen counterparts was devised. After condensation of 4-formylazetidin-2-ones 49 with different primary
amines, 4-imidoyl-β-lactams 52 were obtained in high yields. Reduction of these imines 52 with
NaBH4 in methanol or ethanol afforded optically active piperazine and 1,4-diazepane annelated β-lac-
tams 53 in good to high yields in a one-step procedure (Scheme 11).
The construction of bicyclic azetidin-2-ones in which the second ring is attached to the β-lactam
unit at the 3,4-position (“C-fused” bicyclic β-lactams) comprises an interesting challenge as an alter-
native for the conventional 1,4-fused bicyclic β-lactams. A suitable entry into this class of heterocycles
was provided through internal nucleophilic displacement of a leaving group present in the side chain at
the 4-position by a nucleophile attached to the C3 of the β-lactam ring. At first, hydrogenolysis of the
benzyl ether substituent in 3-benzyloxy-4-(2-bromo-1,1-dimethylethyl)azetidin-2-ones 54 using palla-
dium on activated carbon in methanol afforded the corresponding cis-3-hydroxy-β-lactams after 16 h at
room temperature. Formation of the premised cis-6-aza-2-oxabicyclo[3.2.0]heptan-7-ones required the
addition of Et3N to these cis-3-hydroxy-β-lactams, resulting in bicyclic β-lactams 55 in 82–95 % yield
after reflux for 16 h in benzene (Scheme 12) [21]. At present, little information regarding this type of
oxygen-containing 3,4-fused β-lactam systems can be found in the literature [22].
Due to the presence of a propiolactam moiety, azetidin-2-ones are ideally suited for the synthesis
of biologically interesting β-amino acids through hydrolysis of the amide bond [23–25]. Accordingly,
the synthesis of the 3-aminotetrahydrofuran-2-carboxylates 56 was accomplished through ring opening
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Scheme 11 Synthesis of bicyclic β-lactams 51 and 53.
of bicyclic cis-β-lactams 55 by means of HCl in methanol in 60–78 % yield (Scheme 12). X-ray analy-
sis of 3-aminotetrahydrofuran-2-carboxylate 56 (R = 4-MeOC6H4) acknowledged the cis-relationship
between the amino group and the ester moiety. Cyclic β-amino acids in which the amino group and the
acid functionality are vicinally attached to an aliphatic ring represent an important challenge due to their
biological utility, as, for example, the antifungal agent Cispentacin [26,27]. Moreover, the synthesis of
the corresponding oxolane derivatives, which are known for their antimycotic activity [28], has become
a relevant challenge in organic chemistry.
In conclusion, 4-haloalkyl-β-lactams can be considered as suitable, flexible, and versatile build-
ing blocks in heterocyclic chemistry. Their applicability toward the synthesis of a whole variety of func-
tionalized heterocycles has been demonstrated, including the preparation of aziridines, azetidines,
pyrrolidines, piperidines, azepanes, pyrrolidin-2-ones, oxolanes, bicyclic β-lactams, and bicyclic γ-lac-
tams. These methodologies are characterized by a high degree of efficiency and stereoselectivity, thus
providing useful entries into different classes of heterocyclic compounds.
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